Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-Leukemia Effects with Venetoclax
Article in Marine Drugs (May 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Marine Drugs (May 2024)
Article in Biomolecules & Therapeutics (April 2024)
Article in Acta Pharmacologica Sinica (February 2024)